Pfizer
 Logo used since 2021 | |
| Type | Public |
|---|---|
| Industry | |
| Founded | 1849 in New York City |
| Founders | |
| Headquarters | The Spiral, New York City , |
Area served | Worldwide |
| Key people | Albert Bourla (Chairman and CEO) |
| Products | |
| Revenue |  US$62.58 billion (2025) |
 US$14.24 billion (2025) | |
| US$7.771 billion (2025) | |
| Total assets | US$208.2 billion (2025) |
| Total equity | US$86.48 billion (2025) |
Number of employees | c. 75,000 (2025) |
| Website | www |
| Footnotes | |
Pfizer Inc. (/ˈfaɪzər/ FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis (apixaban) ($7.9 billion in 2025 revenues, 13% of total revenues), Prevnar (a pneumococcal conjugate vaccine) ($6.5 billion in 2025 revenues, 10% of total revenues), Paxlovid (Nirmatrelvir/ritonavir) ($2.4 billion in 2025 revenues, 4% of total revenues), Vyndaqel (tafamidis) ($6.4 billion in 2025 revenues, 10% of total revenues), Comirnaty (the Pfizer–BioNTech COVID-19 vaccine) ($4.4 billion in 2025 revenues, 7% of total revenues), and Ibrance (palbociclib) ($4.1 billion in 2025 revenues, 7% of total revenues). In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.